Stacey A Cohen

13PUBLICATIONS
90CO-AUTHORS
Haematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 13, 2026
Avatrombopag Versus Placebo for Persistent Chemotherapy-Induced Thrombocytopenia in GI Cancers: The Phase II ACT-GI Trial.

|Feb 27, 2026
Utility of Circulating Tumor DNA to Assess Tumor Response in Patients with Locally Advanced Rectal Cancer Undergoing Neoadjuvant Therapy.

Sakti Chakrabarti, Stacey A Cohen, Antony Tin

|Aug 07, 2025
Real-world Monitoring of ctDNA Reliably Predicts Cancer Recurrence and Treatment Efficacy in Patients with Resected Stages I-III Colon Cancer.

Stacey A Cohen, Vasily N Aushev, George Laliotis

|Jun 13, 2025
Phase Ia/Ib Study of Afatinib with Capecitabine in Patients with Refractory Solid Tumors and Pancreaticobiliary Cancers.

Gentry G King, Kelsey K Baker, Andrew L Coveler

|Oct 07, 2024
Alcohol Consumption and Smoking History at the Time of Diagnosis and the Risk of Colorectal Cancer Recurrence and Mortality: Results from the ColoCare Study.

Nicole C Loroña, Caroline Himbert, Jennifer Ose

|May 08, 2024
Evaluating the utility of ZNF331 promoter methylation as a prognostic and predictive marker in stage III colon cancer: results from CALGB 89803 (Alliance).

Elizabeth S Nakasone, Tyler J Zemla, Ming Yu

Pageof 3

Frequent Collaborators

3 joint publications

Erin M Siegel

3 joint publications

Jane C Figueiredo

3 joint publications

Cornelia M Ulrich

3 joint publications

David Shibata